Sanofi’s shares fell following mixed results of its experimental drug for a deadly lung condition. Itepekimab, a medicine that is being jointly developed by Sanofi and Regeneron, is being tested ...

A new national lung cancer screening program starting in July is expected to detect an extra 1,500 cases each year. Lung cancer is the nation's deadliest cancer and advocates say the new screening ...

This leads to a condition known as interstitial lung disease. The role played by different immune cells in this process has hardly been researched to date. This is where the current work of Dr ...

Ivonescimab plus chemo cut disease progression risk by 48% vs. chemo alone (HR=0.52). Fatal TEAEs were lower with ivonescimab (1.8%) vs. chemo alone (2.8%) in Phase 3 trial. Historic Summer Setup ...

A total of 358 patients were concurrently assigned to receive nivolumab plus chemotherapy (179 patients) or chemotherapy alone (179 patients). The final analysis of overall survival significantly ...

to find pancreatic cancer cell lines that had a tendency to colonize either the lung or the liver. Then, they looked for genomic differences that could reveal why, or even how, these cells ...

Tarlatamab, a bispecific delta-like ligand 3–directed T-cell engager immunotherapy, received accelerated approval for the treatment of patients with previously treated small-cell lung cancer.

One of the ribs was out of position, which caused a collapsed lung. He had a procedure Sunday night to manage the lung and will undergo another procedure to address the rib fractures. The referee ...

"This is a 3D navigational bronchoscopy platform that allows us to biopsy the lungs, especially in very small lung nodules," says Dr. Catalin Nicola. "It allows us to diagnose lung cancer in its ...

Radiation therapy targets lung cancer at all stages, damaging tumor cell DNA to inhibit growth and division. Palliative radiation focuses on symptom relief in polymetastatic disease, using shorter, ...